5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 13.93▼ | 13.93▼ | 13.92▼ | 13.99▼ | 13.79▲ |
MA10 | 13.95▼ | 13.97▼ | 13.98▼ | 13.93▼ | 13.75▲ |
MA20 | 14.00▼ | 14.01▼ | 14.01▼ | 13.84▼ | 13.35▲ |
MA50 | 14.00▼ | 13.99▼ | 13.96▼ | 13.74▲ | 13.76▲ |
MA100 | 13.99▼ | 13.88▲ | 13.87▲ | 13.37▲ | 13.25▲ |
MA200 | 13.89▲ | 13.83▲ | 13.83▲ | 13.77▲ | 13.63▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.013▼ | -0.018▼ | -0.021▼ | 0.007▲ | 0.068▲ |
RSI | 32.079▼ | 35.121▼ | 34.637▼ | 49.517▼ | 53.593▲ |
STOCH | 13.183▼ | 10.873▼ | 14.603▼ | 78.843 | 71.254 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -52.830 | -27.723 |
CCI | -89.525 | -106.024▼ | -119.262▼ | 11.667 | 99.866 |
Wednesday, August 13, 2025 05:42 AM
Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today ...
|
Monday, August 11, 2025 08:01 AM
Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 13.96 | 14.0418 | 13.83 | 13.83 | 147,890 |
14/08/25 | 14.02 | 14.11 | 14.0107 | 14.06 | 125,378 |
13/08/25 | 14.09 | 14.10 | 14.0118 | 14.04 | 148,475 |
12/08/25 | 14.01 | 14.05 | 13.955 | 14.05 | 110,612 |
11/08/25 | 14.01 | 14.02 | 13.90 | 13.97 | 203,768 |
08/08/25 | 14.00 | 14.05 | 13.94 | 13.97 | 222,700 |
07/08/25 | 13.93 | 14.00 | 13.92 | 14.00 | 285,418 |
06/08/25 | 13.80 | 13.91 | 13.79 | 13.84 | 194,400 |
05/08/25 | 13.78 | 13.85 | 13.71 | 13.77 | 221,774 |
04/08/25 | 13.67 | 13.85 | 13.67 | 13.76 | 146,600 |
|
|
||||
|
|
||||
|
|